Our findings indicate that molecular genetic testing using residual DBS samples is possible; this technique will be used in a future prospective cohort study to clarify the relationship between homozygous SMN2 deletion and motor neuron diseases. This evidence concerns the gene SMN2 and motor neuron disorder.